Synthesis, DNA-binding, and interferon-inducing properties of isatin and benzoisatin hydrazones

Pharmaceutical Chemistry Journal

Volumn 40, Issue 11, 2006, Pages 595-602

  Karpenko, A S ^a   Shibinskaya, M O ^a   Zholobak, N M ^b   Olevinskaya, Z M ^b   Lyakhov, S A ^a   Litvinova, L A ^a   Spivak, M Ya ^b   Andronati, S A ^a  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b ZABOLOTNY INSTITUTE OF MICROBIOLOGY AND VIROLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

(4 METHYLPIPERAZIN 1 YL)ACETIC ACID (2 OXO 1,2 DIHYDROINDOL1 YLIDENE)HYDRAZIDE; (4 METHYLPIPERAZIN 1 YL)ACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; (4 METHYLPIPERIDIN 1 YL)ACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; (4 METHYLPIPERIDIN 1 YL)ACETIC ACID (2 OXO1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; AZEPAN 1 YLACETIC ACID (2 OXO 1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; AZEPAN 1 YLACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; DIETHYLAMINOACETIC ACID (2 OXO 1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; DIETHYLAMINOACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; INTERFERON; ISATIN; ISATIN DERIVATIVE; MORPHOLIN 4 YLACETIC ACID (2 OXO 1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; MORPHOLIN 4 YLACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; PIPERIDIN 1 YLACETIC ACID (2 OXO 1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; PIPERIDIN 1 YLACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; PYRROLIDIN 1 YLACETIC ACID (2 OXO 1,2 DIHYDROINDOL 1 YLIDENE)HYDRAZIDE; PYRROLIDIN 1 YLACETIC ACID (2 OXO 2,3 DIHYDROBENZO[E]INDOL 1 YLIDENE)HYDRAZIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DNA BINDING; DRUG SYNTHESIS; NONHUMAN;

EID: 34247393325     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-006-0201-9     Document Type: Article

References (18)

1. E. A. Lyakhova, S. A. Lyakhov, L. A. Litvinova, et al., Khim.-Farm. Zh., 37(4), 16-21 (2003).
2. E. A. Lyakhova, S. A. Lyakhov, L. A. Litvinova, et al., Khim.-Farm. Zh., 39(4), 16-20 (2005).
3. Ukrainian Patent No. 65845A (2004); Byul. Izobret., No. 4 (2004).
4. J. C. Logan, M. P. Fox, J. H. Morgan, et al., J. Gen. Virol., 28(3), 271-283 (1975).
5. A. I. Potopal'skii, L. V. Lozyuk, A. N. Mirolyubova, and B. F. Bessarabov, Isatizon: Antiviral, Antitumor, Antileukemic Drug [in Russian], Naukova Dumka, Kiev (1991).
6. D. T. Graves, L. M. Velea, Current Org. Chem., 4(9), 915-929 (2000).
7. E. Labisbal, A. Sousa-Pedrares, W. Kaminsky, D. X. West, Z. Naturforsch., 57b, 908-913 (2002).
8. N. Donaldson, Chemistry ad Technology of Naphthalene Derivatives [Russian translation], Goskhimizdat, Moscow (1963), pp. 69-70.
9. W. Rohde, R. Shafer, J. Idriss, and W. Levinson, J. Inorg. Biochem., 10(3), 183-194 (1979).
10. K. Hirata, J. Araya, S. Nakaike, et al, Chem Pharm Bull (Tokyo), 49(1), 44-48 (2001).
11. J. Sturm, L. Schriber, Biopolymers, 20, 765-782 (1981).
12. I. Antonini, P. Polucci, L. R. Kelland, et al., J. Med. Chem., 42(14), 2535-2541 (1999).
13. G. F. Lakin, Biometrix [in Russian], Vysshaya Shkola, Moscow (1990), pp. 208-303.
14. Preclinical Investigation of Drugs (Methodological Recommendations) [in Ukrainian], O. V. Stefanov (ed.), Kiev (2001), pp. 390-392.
15. V. I. Votyakov, I. E. Boreko, G. V. Vladyko, et al., Primary Evaluation of Antiviral Properties of Synthetic and Natural Compounds (Methods and Recommendations) [in Russian], Minsk (1986), pp. 18-25.
16. L. M. Vil'ner, Current Problems in the Screening and Subsequent Characterization of Antiviral Drugs of the Interferonogen Type, in: Methodological Questions in R&D of Antiviral Drugs [in Russian], Minsk (1977), pp. 134-136.
17. Methods of Testing and Evaluation of Antiviral Activity of Chemical Compounds with Respect to Influenza Virus (Methodological Recommendations) [in Russian], Leningrad (1977), p. 35.
18. Immunological Diagnostics of Viral Infections [in Russian], T. V. Peradze (ed.), Meditsina, Moscow (1985).